|
June 25, 2001
Q
"With the media covering the mother's recent murder of her
children, I wondered what some of the current thinking on depression
after giving birth?"
A
Treatment with 17ß-estradiol can
rapidly reduce severe postpartum depression in estrogen-deficient
women, according to Finnish researchers.
In spite of multiple contacts with
health providers, women with postpartum depression often remain
unrecognized and untreated.
Within the first week of the 8-week
treatment period, depressive symptoms diminished significantly and
serum estradiol concentrations increased. By the end of the second
week, depression rating scores were compatible with clinical
recovery in 19 of the patients studied.
By correcting the hormonal balance
with physiologic...estrogen, a quick effect on mood improvement may
be reached in a group of young mothers vulnerable to depression.
J Clin Psychiatry
2001;62:332-336.
June 18, 2001
Q
"Do they ever use hypnosis rather than epidurals to reduce the
pain of childbirth?"
A:
Self-hypnosis during
childbirth may ease some of the pain of labor, lower the risk of
medical complications and reduce the need for surgery, study results
suggest.
Hypnotherapy has been shown to reduce
pain and the need for anesthesia, as well as ease anxiety and fear
during childbirth, Dr. Paul G. Schauble and colleagues note in the Journal
of Family Practice for May. The use of hypnosis during
pregnancy to prepare women for delivery may be key since it gives
them a sense of control, they say.
To investigate, the researchers, who
are at the University of Florida in Gainesville, assigned 42
pregnant teenagers to receive either counseling or four sessions of
instruction in self-hypnosis for childbirth. Teens in the hypnosis
group learned deep relaxation and imagery techniques to help them
cope with pain. They also received suggestions to help them respond
to possible complications and boost their confidence in their
ability to manage anxiety.
According to the report, only 1 of 22
patients in the hypnosis group remained in the hospital longer than
2 days after delivery, compared with 8 of 20 patients who did not
learn self-hypnosis. None of the patients in the hypnosis group
needed surgical intervention, compared with 60% of those in the
non-hypnosis group.
In addition, fewer patients in the
hypnosis group experienced complications such as high blood pressure
or vacuum-assisted delivery, opted for medical anesthesia or
oxytocin, or required medication after delivery.
"This study provides empirical
data demonstrating that the use of hypnosis in preparing pregnant
women for labor and delivery reduces the risk of complications,
decreases the need for medical intervention...and promotes safer,
more comfortable delivery for mother and child. We anticipate this
will lead to a reduction in the costs involved in childbirth."
J Fam Pract
2001;50:441-443.
June 11, 2001
Q
"Of those with depression, how many seek care...or do they try
to ignore it?"
A
Less than 20% of the
millions of American adults who have experienced clinical depression
or anxiety have ever been treated for the disorders. In total, 93%
of undiagnosed people in a recent study "do not associate
their symptoms with a mental health disorder," despite the fact
that 44% of people in this group say that their symptoms cause them
"significant emotional pain and restricted functioning,"
in daily life, the researchers noted. Close to half (44%) of those
who would not seek diagnosis or therapy believe they can treat
themselves. Among this group, remedies include prayer (41%), rest
(38%), exercise (37%), sleep (31%), or emotional support from family
and friends (31%). Receiving a diagnosis of depression or anxiety is
shameful to many Americans, according to the researchers. Forty-two
percent of people with a formal diagnosis of depression or
generalized anxiety disorder report being embarrassed by their
symptoms compared with 17% of those who have never been diagnosed.
Only 45% of those who have been diagnosed with the disorders expect
their treatment will provide even initial symptom relief.
June 4, 2001
Q
"Was there not something
about a "notch gene" that causes schizophrenia?"
A
Previous evidence
linking the NOTCH4 gene with schizophrenia was not replicated in
other populations, according to two reports in the June issue of Nature
Genetics.
Linkage disequilibrium mapping was
used in an earlier study to identify a putative link between NOTCH4
and schizophrenia in 80 British parent-offspring trios. NOTCH4
belongs to a family of genes involved in determining cell fate.
No new study found any evidence for
an association between NOTCH4 and schizophrenia. In fact, each
putative schizophrenia-associated allele had a somewhat lower
frequency among schizophrenics than among controls.
There is not a general risk conferred
by these markers to all schizophrenics of the magnitude originally
found.
Nat Genet 2001;28:126-129
May 27, 2001
Q
"Depression is chemical is it not? So it really does not matter
what happens in life...you either get depressed or you don't,
right?"
A
This overview may be helpful to you. "Our
concept of the etiology of depression has changed from very
simplistic models to complex ones. It is becoming increasingly
evident that depression is a heterogeneous, systemic illness,
involving an array of different neurotransmitters, neurohormones,
and neuronal pathways. The notion that depression is the result of a
simple hereditary process or traumatic life event that ultimately
leads to a single neurotransmitter deficiency is simply
unsubstantiated by the evidence.
It is now assumed that depression may
result from a complex interaction between genetic predisposition to
the illness and early untoward life events such as child abuse or
neglect. Such interactions undoubtedly induce significant changes in
the CNS. Specifically, these interactions result in hyperactive CRF
and NE systems, which are the main moderators of the stress
response. The CRF and NE systems exert wide influences on multiple
regions of the CNS, as well as the periphery, via the HPA axis and
the autonomic nervous system. These neurobiological perturbations
may persist into adulthood, leading to a hypersensitive stress
response system, which overreacts to all forms of stress in adults,
including mild stress or daily life events. It is hypothesized that
this hypersensitive stress response system underlies, in part, the
neurobiological vulnerability to depression and anxiety. After
exposure to repetitive or chronic stress, genetically vulnerable
individuals likely develop mood and/or anxiety disorders. The
current limitations of this theory are that many depressed patients
apparently lack 1 of the above-mentioned risk factors (ie, genetic
predisposition or early trauma).
There are many neurobiological
substrates for depression that we have not reviewed. Research has
provided evidence about the potential role of substance P, a
neuropeptide, in the pathogenesis of depression. Moreover, there is
some evidence supporting a role of dopamine circuit dysfunction in
depression.Interestingly, nomifensine, a selective dopamine reuptake
inhibitor, was an effective antidepressant, but was removed from the
market because of an unacceptably high rate of hemolytic anemia in a
small number of patients. Also, several studies have documented that
increased cholinergic activity might be associated with depressed
mood; however, the role of acetylcholine in the development of
depression remains obscure. Because neurotransmitters ultimately
produce their effects via alterations in intracellular mechanisms,
such as second messengers and neurotropic elements (factors and gene
expression), these factors have received more attention in the last
decade.
The new findings in the neurobiology
of depression have led to a better understanding of the action of
antidepressants, which have been found to return the alterations of
the CRF system back to normal. Also, there has been an active search
for newer agents to target the newly discovered neurotransmitters.
Novel agents, such as CRF receptor and NK-1 antagonists, are still
experimental, but they hold promise for a better antidepressant
treatment, especially for refractory patients, and they have a more
tolerable side-effect profile compared with that for the currently
available agents.
The new discoveries regarding the
"stress-diathesis model" of depression have stimulated
renewed interest in the paramount role of child abuse and other
early untoward life events in the pathogenesis of depression.
Because multiple studies have shown the long-term deleterious
effects of early trauma on vulnerability to depression, and because
child abuse is tragically a common societal problem (at least 1
million cases verified each year in the US), identification of and
intervention for such vulnerable individuals is an important
goal."
May 20, 2001
Q
"I am nervous almost all
the time...have been for as long as I can remember. I am wondering
if this is common and what can be done."
A There
is a condition called generalized anxiety disorder.
Patients with
generalized anxiety disorder experience worry or anxiety and a
number of physical and psychologic symptoms. The disorder is
frequently difficult to diagnose because of the variety of
presentations and the common occurrence of comorbid medical or psychological
conditions.
The lifetime
prevalence is approximately 4 to 6 percent in the general population
and is more common in women than in men. It is often chronic, and
patients with this disorder are more likely to be seen by family
physicians than by psychologists.
Treatment
consists of pharmacotherapy and various forms of psychotherapy. The
benzodiazepines (Valium, Ativan, etc) are used for short-term
treatment, but because of the frequently chronic nature of
generalized anxiety disorder, they may need to be continued for
months to years. Buspirone (BuSpar) and antidepressants (e.g. Paxil,
etc) are also used for the pharmacologic management of patients with
generalized anxiety disorder. Patients must receive an appropriate
pharmacologic trial with dosage titrated to optimal levels as judged
by the control of symptoms and the tolerance of side effects.
Psychiatric consultation should be considered for patients who do
not respond to an appropriate trial of pharmacotherapy. (Am Fam
Physician 2000;62:1591-600,1602.)
May 13, 2001
Q:
"Is PMS really a disorder or is it my wife's excuse for being
bitchy?"
A:
Whether premenstrual
dysphoric disorder (PMDD) is a real disease or diagnostic label for
normal phenomena has been a subject of hot debate. Two new studies
using strict criteria to determine the prevalence of PMDD suggest two
things: It is real, and it is significantly disruptive in some women's
lives.
PMDD is a severe form of
PMS, and patients typically have symptoms suggestive of depression,
anxiety, or other psychiatric conditions. The condition affects almost
all menstrual cycles and complicates normal daily functioning in
patients.
The two studies -- one of
younger women and one of older -- appear to indicate that the
conventional prevalence estimates of 3-5% are roughly correct.
One study of 513 women
aged 36-44 showed that 33 (or 6.4%) met criteria for the disorder
listed in the APA's Diagnostic and Statistical Manual.
PMDD was associated with
lower education, a history of major depression, current cigarette
smoking, and working outside the home.
Because the study only
looked at older premenstrual women, the prevalence may have been
slightly higher than what actually exists. In addition, subjects in
the study were followed for only a month.
Preliminary findings from
another study of PMDD among females aged 13-55 showed a lower
prevalence. Of 430 subjects studied, just seven -- or less than 2% --
met criteria for a diagnosis of PMDD, according to the survey
sponsored by the National Institute of Mental Health.
Of the 423 women in the
sample who did not meet criteria for a diagnosis, 73% said they were
less productive and efficient at home, 68% said their symptoms
interfered with their ability to get things done at home, and 64% said
their symptoms interfered with relationships at home.
Smaller but still
significant percentages of women not meeting criteria for a diagnosis
of PMDD said their symptoms interfered with social activities, ability
to do their work, or with relationships at work.
By distinguishing true
PMDD from chronic depression and anxiety, physicians can tailor
therapy to their patients. Specifically, they should try a course of
antidepressants for the 14-day period prior to menses, for two or
three cycles.
May 6, 2001
Q
"My husband quit smoking with ease. I am having a terrible time.
My best friend and her husband showed the same pattern. Do women have
a more difficult time quitting?"
A
A number of medical and
social factors combine to make it more difficult for women to quit
smoking than men.
In the May issue of CNS Drugs,
data show that the "benefit from nicotine replacement is not as
great in women as it is for men."
Medications that are not nicotine
replacement therapies, such as clonidine, bupropion and mecamylamine,
may produce comparable smoking cessation rates between women and men,
he notes.
Among the other factors that make it
harder for women to stop smoking is fear of gaining weight and
antismoking medication restrictions during pregnancy. In addition, the
effects of antismoking drugs and smoking withdrawal can have a
negative impact during menses.
Women are less likely to receive social
support that fosters smoking cessation and are more susceptible to the
influence of smoking-associated environmental cues, such as smoking
with friends or being in a specific mood.
Particularly, women need to learn
coping strategies to deal with socially conditioned cues that are
barriers to quitting. Although one may handle the nicotine withdrawal
reasonably well with gums and patches, something still needs to be
done for all the condition cues that make quitting smoking difficult.
Since these are probably more important for women than men, women are
at a disadvantage.
CNS Drugs 2001;15:391-411.
April 30, 2001
Q
"My daughter is bulimic, and my son has been diagnosed with
borderline personality disorder. He has been doing very well in DBT;
would this work for my daughter?"
A
Dialectical behavior therapy, a
form of therapy originally developed to treat parasuicidal behavior in
patients with borderline personality disorder, also seems to help
bulimics break out of the binge/purge cycle. Although not effective in
all bulimic patients, it significantly reduces binge/purge episodes,
according to a report in the April issue of the American Journal of
Psychiatry.
Dialectical behavior
therapy, or DBT, says that binge eating is a way of dealing with
unbearable feelings. It teaches new ways to control and manage
emotions, replacing dangerous behaviors with much healthier options.
It's a way of distracting oneself, it's a behavior that regulates
[mood]. According to this therapy, an inability to self-soothe is at
the core of bulimia.
People who display
parasuicidal behavior hurt themselves to feel better, and there seems
to be a direct analogy between those behaviors and binge eating.
Bulimics are using food to avoid painful emotional states.
In fact, many bulimics
report entering a detached, trancelike state while binging and
purging.
In DBT, patients are not
told that their feelings are wrong, but rather that they need to find
a more positive way to manage them. They learn mindfulness -- stepping
back and being conscious of the moment without judging it as good or
bad -- and other emotion-regulating skills, so that their feelings
have less influence on their behavior.
They also learn distress
tolerance -- coping with situations as they are -- and methods of
self-soothing and distraction, and they practice these skills until
they replace the automatic binge/purge response.
After 20 weeks, 28.6% of
women in the DBT group had stopped binging and purging completely,
while 35.7% reported significant reductions (88%) in the frequency of
binge/purse episodes. Five patients continued to fulfill criteria for
bulimia nervosa.
Bulimics do not have
skills for dealing with their emotions. Food is used to create walls
because they don't have a way to let what is going on outside while
remaining calm inside.
The first important skill
to learn is stepping back from whatever is so overwhelming and just
looking at it without engaging in compulsive behaviors to avoid it.
April 23, 2001
Q
"My wife's sex drive has really decreased since she has been
taking anti-depressants. I have never heard of this side effect."
A
As many as half of patients
taking SSRIs have resultant sexual dysfunction. A report in the March Journal
of Clinical Psychiatry indicates that sustained-release bupropion
(Wellbutrin SR) may be an effective antidote.
You can interfere with
sexual function by interfering with serotonin tone. With SSRIs you
make the system more active. Bupropion works in the dopamine system,
which is linked to desire.
Bupropion tends to be a
well-tolerated medication. Sometimes it makes patients a bit jittery,
sometimes gives them headaches, but it does treat sexual dysfunction
well under the dose at which one sees an increased incidence of
seizure.
April 16, 2001
Q
"I gather that most people treat insomnia with drugs. Is there
any form of psychotherapy that works for my problems with sleep?"
A
Cognitive-behavioral therapy
(CBT) focusing on changing specific thoughts, behaviors, and
assumptions can help transform that nighttime tossing and turning into
a time of rest and relaxation, say researchers reporting in the April
11 edition of JAMA.
The treatment is widely
used in the treatment of depression and anxiety disorders, employs a
combination of education and practice exercises -- not unlike homework
assignments -- to alter "dysfunctional thoughts, beliefs, and
assumptions.
Results showed that
patients receiving the CBT program had an average 54% reduction in the
amount of time they spent awake after having fallen asleep. Patients
in the muscle relaxation program had only a 16% reduction, while the
sham treatment group had only a 12% reduction.
Edinger explains that when
CBT is applied to insomnia, it seeks to reverse the underlying
beliefs, assumptions, and habits that contribute to a pattern of
sleeplessness. For example, people with insomnia are liable to have
fallen into a pattern of using their time on the pillow to watch
television, read, or plot and plan anxiously for the next day. Over
time, the pattern becomes a habit, and lying in bed gradually becomes
associated with wakefulness rather than sleep.
With CBT, participants are
trained not to think and worry while lying in bed, not to read or
watch television in bed, and never to lie in bed for long periods.
They are told to avoid daytime napping and to establish a standard
rising time. Time-in-bed restrictions are designed to reinforce the
stimulus control by helping patients to learn to use the bed only for
sex and sleeping.
April 9, 2001
Q
"I have heard of "runner's high" and that some people
become depressed when they stop running regularly. Is there any know
relationship between running and depression?"
A
It was recently written that "A
simple program of regular aerobic exercise can substantially improve
depression scores in patients with moderate to severe major
depression, despite prior failures with pharmacologic therapy.
Overall, exercise training caused a
clinically significant drop in depression scores during the 10 days.
Of the twelve patients in the study, six demonstrated
"substantial" improvements — including five of the
patients with refractory depression — two demonstrated slight
improvements and four remained unchanged.
"Aerobic exercise may certainly be
used as complementary therapy in severely depressed patients who
receive antidepressants and do not have contraindications for
exercise. Since there is no evidence about the long-term effects of
exercise [and] compliance and outcomes when stopping training, aerobic
exercise should not be used as first-line therapy for depression until
confirmatory studies have been concluded."
Br J Sports Med
2001;35:114-117.
April 2, 2001
Q
"My teenager has been depressed and talking about life is not
worth living. I know teenagers do this, but I am also concerned. Yet,
I feel that if I bring up my concerns about suicide, my mentioning it
might increase the chance that he would do it. What do you do with
such a situation?"
A
"According to a new study,
doctors need to start asking teens about their mental health status
because all evidence indicates that they won't volunteer the
information on their own. Psychological problems may be as much as
seven times more common among teens than their medical files indicate,
according to a study in a recent issue of the journal Family
Practice.
This gap is dangerous
because teen mental health problems -- if left untreated -- may result
in academic problems and even suicide. The good news, though, is that
mental health problems in children and adolescents -- from eating
disorders and depression to stress and attempted suicide -- are very
often treatable.
Another red flag raised by
the new study: Teens with mental health problems -- including those
who attempt suicide -- are indistinguishable from their nonemotionally
disturbed peers in terms of how often they visit the doctor. This
finding contradicts earlier work that suggested depressed teens have
more contact with healthcare professionals than other youths.
Overall, just 4% consulted
their doctor about mental health problems, and just 3% of all case
notes had information about emotional well-being, the researchers
report. One percent of the adolescents had attempted suicide, and one
in five had done so on more than one occasion.
"It could be argued
that adolescents are not bringing their mental health concerns to the
attention of their [general practitioner]. Alternatively, it is
possible that [general practitioners] do not pick up and respond to
... comments and nonverbal cues from adolescents," write
researchers from the departments of child and adolescent psychiatry
and general practice at the University of Glasgow, Scotland.
Their solution? Ask teens
to fill out questionnaires assessing their mental health before they
meet with their doctor, as they may find it easier to disclose
emotional problems in this manner.
"Because the risk of
school failure and suicide is quite high in depressed children and
adolescents, prompt referral or close collaboration with a mental
health professional is often necessary," Son and Kirchner
conclude in the Nov. 15, 2000, issue of the American Family
Physician.
At the root of the
resistance, she says, is that people don't like to admit that they
need help coping with emotional issues. They feel they should be tough
enough to take care of it on their own.
That's why it's important
to let teenagers know that it's OK -- that emotional problems are
normal -- and that they should not be afraid to discuss their concerns
with their doctor. With parents, some are attuned to mental well-being
and others aren't."
|